These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35239818)

  • 1. Cerebrospinal fluid analysis in patients with COVID-19-associated central nervous system manifestations: a systematic review.
    Domingues RB; Leite FBVM; Senne C
    Arq Neuropsiquiatr; 2022 Mar; 80(3):296-305. PubMed ID: 35239818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome.
    Guasp M; Muñoz-Sánchez G; Martínez-Hernández E; Santana D; Carbayo Á; Naranjo L; Bolós U; Framil M; Saiz A; Balasa M; Ruiz-García R; Sánchez-Valle R;
    Front Immunol; 2022; 13():866153. PubMed ID: 35479062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development.
    Espíndola OM; Brandão CO; Gomes YCP; Siqueira M; Soares CN; Lima MASD; Leite ACCB; Torezani G; Araujo AQC; Silva MTT
    Int J Infect Dis; 2021 Jan; 102():155-162. PubMed ID: 33127503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
    Jarius S; Pache F; Körtvelyessy P; Jelčić I; Stettner M; Franciotta D; Keller E; Neumann B; Ringelstein M; Senel M; Regeniter A; Kalantzis R; Willms JF; Berthele A; Busch M; Capobianco M; Eisele A; Reichen I; Dersch R; Rauer S; Sandner K; Ayzenberg I; Gross CC; Hegen H; Khalil M; Kleiter I; Lenhard T; Haas J; Aktas O; Angstwurm K; Kleinschnitz C; Lewerenz J; Tumani H; Paul F; Stangel M; Ruprecht K; Wildemann B;
    J Neuroinflammation; 2022 Jan; 19(1):19. PubMed ID: 35057809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
    Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
    Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes.
    Chaumont H; Kaczorowski F; San-Galli A; Michel PP; Tressières B; Roze E; Quadrio I; Lannuzel A
    Rev Neurol (Paris); 2023 Mar; 179(3):208-217. PubMed ID: 36610823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
    Edén A; Kanberg N; Gostner J; Fuchs D; Hagberg L; Andersson LM; Lindh M; Price RW; Zetterberg H; Gisslén M
    Neurology; 2021 Jan; 96(2):e294-e300. PubMed ID: 33004602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses.
    Pilotto A; Masciocchi S; Volonghi I; De Giuli V; Caprioli F; Mariotto S; Ferrari S; Bozzetti S; Imarisio A; Risi B; Premi E; Benussi A; Focà E; Castelli F; Zanusso G; Monaco S; Stefanelli P; Gasparotti R; Zekeridou A; McKeon A; Ashton NJ; BlennoW K; Zetterberg H; Padovani A
    Clin Infect Dis; 2021 Nov; 73(9):e3019-e3026. PubMed ID: 33395482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms.
    Edén A; Grahn A; Bremell D; Aghvanyan A; Bathala P; Fuchs D; Gostner J; Hagberg L; Kanberg N; Kanjananimmanont S; Lindh M; Misaghian S; Nilsson S; Schöll M; Sigal G; Stentoft E; Studahl M; Yilmaz A; Wang M; Stengelin M; Zetterberg H; Gisslén M
    JAMA Netw Open; 2022 May; 5(5):e2213253. PubMed ID: 35604688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid in COVID-19: A systematic review of the literature.
    Lewis A; Frontera J; Placantonakis DG; Lighter J; Galetta S; Balcer L; Melmed KR
    J Neurol Sci; 2021 Feb; 421():117316. PubMed ID: 33561753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted metabolomics identifies accurate CSF metabolite biomarkers for the differentiation between COVID-19 with neurological involvement and CNS infections with neurotropic viral pathogens.
    Neu F; Nay S; Schuchardt S; Klawonn F; Skripuletz T; Suehs KW; Pessler F
    J Transl Med; 2024 Jul; 22(1):620. PubMed ID: 38961383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid processing in COVID-19-associated neurological syndromes.
    Ziff OJ; Ashton NJ; Mehta PR; Brown R; Athauda D; Heaney J; Heslegrave AJ; Benedet AL; Blennow K; Checkley AM; Houlihan CF; Gauthier S; Rosa-Neto P; Fox NC; Schott JM; Zetterberg H; Benjamin LA; Paterson RW
    J Neurochem; 2022 Apr; 161(2):146-157. PubMed ID: 35137414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes.
    Paterson RW; Benjamin LA; Mehta PR; Brown RL; Athauda D; Ashton NJ; Leckey CA; Ziff OJ; Heaney J; Heslegrave AJ; Benedet AL; Blennow K; Checkley AM; Houlihan CF; Mummery CJ; Lunn MP; Manji H; Zandi MS; Keddie S; Chou M; Vinayan Changaradil D; Solomon T; Keshavan A; Barker S; Jäger HR; Carletti F; Simister R; Werring DJ; Spyer MJ; Nastouli E; Gauthier S; Rosa-Neto P; ; Zetterberg H; Schott JM
    Brain Commun; 2021; 3(3):fcab099. PubMed ID: 34396099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19.
    Ngo B; Lapp SA; Siegel B; Patel V; Hussaini L; Bora S; Philbrook B; Weinschenk K; Wright L; Anderson EJ; Rostad CA; Gombolay GY
    Mult Scler Relat Disord; 2021 Oct; 55():103169. PubMed ID: 34333272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
    Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
    Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
    Alexopoulos H; Magira E; Bitzogli K; Kafasi N; Vlachoyiannopoulos P; Tzioufas A; Kotanidou A; Dalakas MC
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32978291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications.
    Kanberg N; Grahn A; Stentoft E; Bremell D; Yilmaz A; Studahl M; Nilsson S; Schöll M; Gostner JM; Blennow K; Zetterberg H; Padmanabhan N; Cohen R; Misaghian S; Romero D; Campbell C; Mathew A; Wang M; Sigal G; Stengelin M; Edén A; Gisslén M
    J Infect Dis; 2024 Feb; 229(2):493-501. PubMed ID: 37874918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus.
    Tyrberg T; Nilsson S; Blennow K; Zetterberg H; Grahn A
    J Neurovirol; 2020 Oct; 26(5):719-726. PubMed ID: 32816287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system complications in SARS-CoV-2-infected patients.
    Li Z; Lin D; Xu X; Liu X; Zhang J; Huang K; Wang F; Liu J; Zhang Z; Tao E
    J Neurol; 2023 Oct; 270(10):4617-4631. PubMed ID: 37573554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.